Miami Healthy Heart Initiative a Behavioral Study on Cardiovascular Risk Factors
Launched by UNIVERSITY OF MIAMI · Jun 28, 2010
Trial Information
Current as of July 25, 2025
Completed
Keywords
ClinConnect Summary
Disparities in the epidemiology of cardiovascular disease (CVD) risk factors among Latinos have been extensively described; however, traditional medical models of CVD risk reduction have not been very effective in Latinos. One promising strategy is the use of community-based community health workers (CHWs). CHWs have long been used in Latin-America as an integral part of their health care delivery system. Further, preliminary data from our prior pilot diabetes self-management CHW program have shown improvements in lipids. However, because of a lack of effectiveness data from studies using r...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients age 35-70 years
- • Receiving care at ACC clinic (2 visits with a primary care provider in the previous year)
- • Living in Miami-Dade county (based on zip codes)
- • Had a hemoglobin A1C done within the past year, with the latest value being \>=8.0
- Exclusion Criteria:
- • Patients whose Primary Doctor believes are not appropriate candidates for participation
- • Type 1 diabetics (identified by Primary Doctor or those with diabetes diagnosed when under age 25).
- • Patients who do not self identify as Hispanic
- • Any life-threatening or extreme medical comorbidity
- • Having a diabetes diagnosis for less than a year
- • Planning to move out of the neighborhood during the next year
- • Participation in any other CVD or diabetes intervention study
- • Arm circumference of greater than 47 cm (oscillometric cuffs do not give accurate readings)
About University Of Miami
The University of Miami, a leading academic institution, is dedicated to advancing medical research and improving patient care through innovative clinical trials. With a commitment to excellence in education and research, the university fosters collaboration among multidisciplinary teams to explore new therapies and treatment modalities. Its extensive clinical programs are supported by state-of-the-art facilities and a diverse patient population, enabling the exploration of cutting-edge solutions to complex health challenges. The University of Miami is poised to contribute significantly to the field of medicine through its rigorous scientific inquiry and a steadfast commitment to ethical research practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Miami, Florida, United States
Patients applied
Trial Officials
Olveen Carrasquillo, MD, MPH
Principal Investigator
University of Miami
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials